top of page

>

>

What is the go-to-market strategy in the U.S. for an Asia-based medical device startup company?

Service Areas
Therapeutic Areas

Other Therapeutic Areas

Client Type

Mid-size Pharma

Client Problems

  • Go-to-market strategy in the US and Asia


  • Investment business case for lead product, and impact on company valuation for fundraising


  • Need for a “roadshow” presentation about the company’s U.S. value proposition

What We Did

  • Market landscape analysis


  • Product revenue forecasting


  • Competitive differentiation analysis


  • Investment valuation (net present value; NPV)


  • Sales force structure and growth analysis

Our Results And Insight

  • Prioritized product features for
    differentiation


  • Go-to-market U.S. strategy, including salesforce


  • Determined U.S. revenue potential


  • Analyzed investment valuation (NPV)
case_study_image_placeholder.png
case_study_image_placeholder.png
case_study_image_placeholder.png
case_study_image_placeholder.png

See other case studies

Commercial Strategy case studies >

Other Therapeutic Areas case studies >

Service Areas Details

Commercial Strategy (Go-to-market Strategy, Valuation, Investment Deck Preparation)

Therapeutic Areas Details

Other Therapeutic Areas (Medical Devices)

Featured Consultants
bottom of page